Intermolecular Inc (IMI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IMI Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Intermolecular Inc balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2019)
(Mar 31 2019) (Dec 31 2018) (Sep 30 2018) (Jun 30 2018)
Assets
Cash & cash equivalent2.16
Short-term Investments, Total21.75
Cash & Short-term Investments23.00
Accounts receivable1.94
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.00
Total Current Assets26.86
Equipment/Property/Plant Net2.81
Intangible Assets1.89
Long-term investments0.00
Other Assets, Noncurrent13.72
Total Assets45.28
Liabilities
Accounts Payable, Current AC0.11
Accrued Liabilities, Current3.58
Other Liabilities, Current1.98
Deferred Revenue, Current DE0.00
Total Current Liabilities5.66
Total Long-term Debt0.00
Deferred Rent Credit, Noncurrent DE0.00
Other liabilities, Noncurrent11.83
Total Liabilities17.50
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock216.97
Retained Earnings / Accumulated Deficit-189.27
Other Equity0.03
Common Stockholder's Equity27.78
Total Stockholder's Equity27.78
Liabilities & Stockholder's Equity45.28
4 historic quarters locked

Sign in to unlock the full Intermolecular Inc balance sheet history.

About IMI Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.